News
Stony Brook Biomedical Discovery Advances New Approach to Pain Relief Without Opioids
The experimental treatment, known as ART26.12, is a first-in-class, non-opioid therapy developed to target neuropathic pain, a severe and often debilitating condition affecting millions of Americans (read more)
Biological Research Paper on Cancer Cells Awarded Carafoli Medal by BBRC
A 2025 research paper by Hyungjin Kim, a Professor in the Renaissance School of Medicine Department of Pharmacological Sciences, has been awarded the prestigious Carafoli Medal. (read more)
The Ojima Distinguished Lectureship Award in Chemistry - Dr. Eric Jacobsen, Honoree (2026)
Now in its fifth year, this year’s Award honored Eric Jacobsen, Sheldon Emery Professor of Chemistry at Harvard University (read more)
Non-Opioid Pain Therapy Discovered at Stony Brook Advances with $11 Million Private Investment
The compound was discovered and initially developed by Martin Kaczocha, Professor
in the Department of Anesthesiology at the Renaissance School of Medicine, and Iwao
Ojima, Distinguished Professor in the Department of Chemistry and Director of ICB&DD
(read more)
ICB&DD Welcomes Dr. Jill Alty as a New Member
Dr. Jill Alty is an Assistant Professor in the Department of Chemistry. (Read more)
Following Light to New Chemical Discoveries with Dr. Jeff Lipshultz
Dr. Jeff Lipshultz is an Assistant Professor in the Department of Chemistry. His work sits at the intersection of foundational science and translational research,
pushing the boundaries of organic chemistry toward applications in medicine, advanced
materials and sustainable manufacturing. (read more)
Rewriting Cancer Pathways with Dr. Agnieszka Bialkowska
Dr. Agnieszka Bialkowska is an Associate Professor in the Department of Medicine,
Renaissance School of Medicine at Stony Brook University. (read more)
ICB&DD 19th Annual Symposium "Drug Discovery & AI: Advances and New Directions" (read more)
ICB&DD Welcomes Dr. Anupam Banerjee as a New Associate Member
Dr. Anupam Banerjee, Senior Postdoctoral Research Associate, Laufer Center for Physical
and Quantitative Biology (read more)
See photo galery Friday June 6
See photo galery Saturday June 7
Message from the Director
Dr. Iwao Ojima, Distinguished Professor and Director, ICB&DD
Welcome to the Institute of Chemical Biology & Drug Discovery
The primary objective of ICB&DD is to establish a world-class “Center of Excellence” in chemical biology and drug discovery at Stony Brook. The rapid and impressive advancement of chemical biology in the last decades clearly demonstrated that solutions for vast majority of medical problems rely on the understanding of the molecular basis of diseases, therapeutic targets, drug actions, and drug resistance. ICB&DD promotes highly productive interdisciplinary and multidisciplinary research bridging the West, East and South campuses as well as Brookhaven National Laboratory to attack major and significant biomedical problems to find solutions including the discovery of novel therapeutic drugs. ICB&DD significantly contributes to the advancement of a truly comprehensive biomedical research enterprise from molecular science to clinic at Stony Brook.
